Bharat Biotech completes clinical trials of India's first intranasal Covid vaccine, says 'it's safe'
Suchitra K Ella, Joint Managing Director, Bharat Biotech, said, "On this Independence Day, we are proud to announce the successful completion of clinical trials for BBV154 intranasal vaccine. If approved, the intranasal vaccine will make it easier to deploy in mass immunisation campaigns with an easy-to-administer formulation and delivery device.'
Aug 15, 2022, 17:54 PM IST
BBV154, Bharat Biotech’s intranasal vaccine, gets DCGI’s approval for booster dose trials
The trials of Bharat Biotech's intranasal vaccine, BBV154, will take place at nine different sites across the country.
Jan 28, 2022, 15:55 PM IST
